Literature DB >> 18810458

[Anterior ischemic optic neuropathy: Etiology, pathogenetic mechanisms and therapy].

R Unsöld1.   

Abstract

Ischemic optic neuropathy is caused by ischemia of the optic nerve head in the region of the lamina cribrosa. Differentiation is made between arteritic (AION) and nonarteritic (NAION) forms. AION is the most common ophthalmological manifestation of giant cell arteritis and is usually well controlled with systemic steroid therapy. Temporal artery biopsy for confirmation of the diagnosis is mandatory. NAION is not a disease entity but rather the common pathogenetic pathway of a large variety of diseases and conditions and is often the result of several interacting factors. For this reason, there is no "standard therapy" for NAION. Careful interdisciplinary work up in NAION frequently reveals previously unrecognized diseases requiring treatment according to internal medicine standards. Adequate treatment frequently results in improvement of the affected eye and reduced risk of NAION in the other eye or of brain infarction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18810458     DOI: 10.1007/s00347-008-1814-z

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  15 in total

1.  Etiology and pathogenetic mechanisms of optic disc swelling with visual loss. An interdisciplinary prospective pilot study of 102 cases.

Authors:  J Stammen; R Unsöld; G Arendt; E G Vester; P Heering; H Freund; B Strauer; B Grabensee
Journal:  Ophthalmologica       Date:  1999       Impact factor: 3.250

2.  Association between sleep apnea syndrome and nonarteritic anterior ischemic optic neuropathy.

Authors:  Daniel S Mojon; Thomas R Hedges; Bruce Ehrenberg; Emely Z Karam; David Goldblum; Alex Abou-Chebl; Matthias Gugger; Johannes Mathis
Journal:  Arch Ophthalmol       Date:  2002-05

3.  Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both.

Authors:  J L Mas; C Arquizan; C Lamy; M Zuber; L Cabanes; G Derumeaux; J Coste
Journal:  N Engl J Med       Date:  2001-12-13       Impact factor: 91.245

Review 4.  Optic disk risk factors for nonarteritic anterior ischemic optic neuropathy.

Authors:  R M Burde
Journal:  Am J Ophthalmol       Date:  1993-12-15       Impact factor: 5.258

5.  Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders.

Authors:  S S Hayreh; M B Zimmerman; P Podhajsky; W L Alward
Journal:  Am J Ophthalmol       Date:  1994-05-15       Impact factor: 5.258

6.  Nonarteritic anterior ischemic optic neuropathy. A case-control study of potential risk factors.

Authors:  D M Jacobson; R A Vierkant; E A Belongia
Journal:  Arch Ophthalmol       Date:  1997-11

7.  Systemic diseases associated with nonarteritic anterior ischemic optic neuropathy.

Authors:  S S Hayreh; K M Joos; P A Podhajsky; C R Long
Journal:  Am J Ophthalmol       Date:  1994-12-15       Impact factor: 5.258

8.  Nonarteritic ischemic optic neuropathy. The impact of tobacco use.

Authors:  S M Chung; C A Gay; J A McCrary
Journal:  Ophthalmology       Date:  1994-04       Impact factor: 12.079

9.  Non-arteritic anterior ischemic optic neuropathy: role of systemic corticosteroid therapy.

Authors:  Sohan Singh Hayreh; M Bridget Zimmerman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-04-11       Impact factor: 3.117

10.  [Neuropathies of the optic nerve in inflammatory systemic diseases and vasculitis. A frequently misdiagnosed early symptom].

Authors:  R Unsöld
Journal:  Ophthalmologe       Date:  1994-04       Impact factor: 1.059

View more
  5 in total

Review 1.  [Optic disc swelling : A compilation of relevant differential diagnoses].

Authors:  V Prokosch; D C Dragnea; S Pitz
Journal:  Ophthalmologe       Date:  2016-11       Impact factor: 1.059

2.  [Ophthalmological findings as a hint for systemic disease].

Authors:  W A Herrmann; H Helbig; M A Gamulescu
Journal:  Internist (Berl)       Date:  2010-04       Impact factor: 0.743

3.  [Bilateral anterior ischemic optic neuropathy following EHEC sepsis and hemolytic-uremic syndrome].

Authors:  T Wortmann; H Jägle; K Hufendiek
Journal:  Ophthalmologe       Date:  2013-07       Impact factor: 1.059

4.  [Retrospective case analysis of ophthalmological and systemic risk factors in patients with retinal vascular occlusion].

Authors:  C Klatt; K Purtskhvanidze; H Hasselbach; F Treumer; J Hillenkamp; J Roider
Journal:  Ophthalmologe       Date:  2010-05       Impact factor: 1.059

5.  Recovery of visual function after administration of dabigatran etexilate.

Authors:  Carl-Ludwig Schönfeld; Marie Fischer; Peter Distelmaier; Sebastian Philipp; Patrick Paquet; Katharina Haller; Linda Meyer
Journal:  Case Rep Ophthalmol       Date:  2014-08-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.